Pharmacotherapy

Page content: Pharmacotherapy policy | Clinical guidelines | Patient resources | Pharmacotherapy newsletter | Forms

Pharmacotherapy policy

• Policy for Maintenance Pharmacotherapy for Opioid Dependence (496kb, pdf)

Clinical guidelines

• National Clinical Guidelines and Procedures for the Use of Methadone in the Maintenance Treatment of Opioid Dependence 2003 (336kb, pdf)
• National Clinical Guidelines and Procedures for the Use of Buprenorphine in the Treatment of Opioid Dependence 2006 (238kb, pdf)

Patient resources

Pharmacotherapy Treatment with Methadone and Buprenorphine
Pharmacotherapy Treatment with Methadone and Buprenorphine (in Vietnamese)

Pharmacotherapy newsletter

This newsletter is for doctors and pharmacists supporting the pharmacotherapy program in Victoria. You’ll find a range of articles related to prescribing and dispensing methadone and buprenorphine. The newsletter is produced by the Department of Human Services Drugs and Poisons Regulation Group.

• Pharmacotherapy newsletter Volume 6 Issue 2 - October 2007 (150kb, pdf)
• Pharmacotherapy newsletter Volume 6 Issue 1 - June 2007 (240kb, pdf)
• Pharmacotherapy newsletter Volume 5 Issue 2 - November 2006 (110kb, pdf)
• Pharmacotherapy newsletter Volume 5 Issue 1 - May 2006 (96kb, pdf)
• Pharmacotherapy newsletter Volume 4 Issue 1 - August 2005 (134kb, pdf)
• Pharmacotherapy newsletter Issue 1 (150 kb, pdf)
• Pharmacotherapy newsletter Issue 2 - November 2002 (80kb, pdf)
• Pharmacotherapy newsletter Issue 3 - May 2003 (350kb, pdf)
• Pharmacotherapy newsletter Issue 4 - November 2003 (50kb, pdf)

Forms

Medical practitioners and community pharmacies may use the following forms to apply for approval to become a pharmacotherapy prescriber or pharmacotherapy supplier, respectively.

• Application for approval as a pharmacotherapy prescriber (49kb, pdf)

• Application for approval as a supplier of pharmacotherapies (48kb, pdf)

Approved medical practitioners may use the following forms to apply for a permit to treat an opioid dependent person with methadone or buprenorphine, notify the Department of Human Services of a patient's drug dependence, notify the department of methadone take away doses, and to notify the Department of Human Services of the termination of a patient's participation in the methadone or buprenorphine program.

• Application to treat an opioid dependent person with methadone or buprenorphine (62kb, pdf)

• Notification of drug dependent person (157kb, pdf)

• Notification to terminate methadone or buprenorphine program (57kb, pdf)

Pharmacists may use the attached pharmacotherapy dispensing support program tax invoice to claim payments for clients who are less than 19 years of age or who have an existing Juvenile Justice order. If the Drugs and Poisons Regulation Group has not notified you that the client is eligible for payment at your pharmacy via a letter then the prescribing doctor may need to fax a statement notifying a change of pharmacy from a particular date on Fax number 1300 360 830.

• Pharmacotherapy dispensing support program tax invoice (28kb, pdf)

Information on notification and Schedule 8 permits

Information on notification and Schedule 8 permits for Medical Practioners

top of page